Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology platform has enabled the innovation of synthetic peptide vaccines designed to prevent or treat infectious diseases, including COVID-19, and chronic diseases, including Alzheimer's, Parkinson’s, migraine, and hypercholesterolemia.. Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human health. The key to the platform is the proprietary library of UBITh peptides, which are immunosilent, avoiding inflammation, and when linked to custom-designed target antigens, can elicit highly specific antibodies.
Company Details
- Employees
- 22
- Address
- 505 Odyssey Way, Exploration Park, Cape Canaveral,florida 32953,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.vaxxinity.com
- Keywords
- Culver City.
- HQ
- Cape Canaveral, Florida
Vaxxinity Questions
Vaxxinity's website is http://www.vaxxinity.com
Vaxxinity's LinkedIn profile is https://www.linkedin.com/company/vaxxinity
Vaxxinity has
22 employees.
View email and phone details for 22
employees at Vaxxinity.
Vaxxinity's industry is
Biotechnology Research
Vaxxinity's top competitors are
Abundance360,
Peter H. Diamandis (Phd Ventures),
Xprize,
Fountain Life,
Celularity Inc.,
Space Adventures,
Human Longevity, Inc.,
United Neuroscience,
Odc Life Sciences,
Singularity University.
Vaxxinity's categories are Biotechnology Research
